DarioHealth
Formerly LabStyle Innovations
Digital Therapeutics for Treating Chronic Conditions
Startup Public Health Tech & Life Sciences Est. 2011
Total Raised
$244.61M
Public
Last Round
$17.5M
17 rounds
Investors
13
13 public
Team
9
201-500 employees
Confidence
95/100
News
221
articles
Patents
1
About
DarioHealth is a global digital therapeutics company aiming to revolutionize how people with chronic conditions manage their health, with offerings that include highly rated diabetes and hypertension solutions. The companys AI-powered digital therapeutic solutions are designed to do more than simply support an individuals disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, high-quality software, coaching, and intuitive, clinically proven digital tools to help individuals improve their health and sustain meaningful outcomes. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets using a performance-based approach to improve its users health.
Classification
Sector
Health Tech & Life SciencesDigital HealthcarePatient EngagementDigital Therapeutics
Core Technology
Platforms & InterfacesMobileData StorageCloudArtificial IntelligenceMachine Learning
Target Customer
Healthcare & Life SciencesHealthcarePatientsProviders
Business Model
B2B2CB2CB2B
Tags
diabetespersonalizationchronic-diseaseremote-monitoringiotmobile-applicationsdigital-healthcaremhealthpatient-engagementmhealthreal-timedata-analyticsmonitoringactionable-insightsbig-dataartificial-intelligencemachine-learningchronic-patientsmobile-platformhealthcare-providerstype-2-diabetesseniorsmental-healthdigital-therapeuticscloud-based
Funding & Events
Sep 2025
PIPE $17.5M
Sep 2018
PIPE $10.3M
Alliance Global Partners (Lead)
Sep 2014
PIPE $4.2M
Undisclosed Investor(s)
Oct 2012
Undisclosed Round $1.2M
Undisclosed Investor(s)
Oct 2011
Undisclosed Round $805K
Undisclosed Investor(s)
Nov 2015
PIPE $2.3M
Undisclosed Investor(s)
May 2023
PIPE $14.3M
May 2021
M&A $30M
May 2013
PIPE $10M
Undisclosed Investor(s)
Jun 2022
Debt Financing $50M
OrbiMed
Jul 2020
PIPE $28.6M
Jan 2025
PIPE $25.6M
Jan 2022
M&A $6M
Jan 2021
PIPE $70M
Nantahala Capital Management, Perceptive Advisors, Driehaus Capital Management, Pura Vida Investments, Phoenix Insurance, Farallon Capital Management, More Investment House
Jan 2021
M&A $31M
Jan 2017
PIPE $5.1M
OurCrowd, Qure Ventures
Feb 2024
PIPE $22.4M
Feb 2024
M&A $30M
Feb 2013
Exit Undisclosed
Dec 2019
PIPE $21.3M
SternAegis Ventures (Lead)
Aug 2015
Exit Undisclosed
News (221)
Oct 16, 2025 · finance.yahoo.com
growth-positive
Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition
Acquisition
Oct 14, 2025 · finance.yahoo.com
growth-positive
Wall Street Analysts Predict a 42.77% Upside in DarioHealth (DRIO): Here's What You Should Know
Oct 13, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced the addition of six...
Oct 13, 2025 · finance.yahoo.com
growth-positive
Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care
Customers
Oct 6, 2025 · finance.yahoo.com
growth-positive
DarioHealth and OneStep Announce Strategic Collaboration to Integrate Smartphone-Only, Clinical-Grade Fall Risk Assessment Technology into Dario's Digital Health Multi-Condition Platform
Partners
Oct 6, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, and OneStep, the U.S. Food and Drug...
Partners
Sep 25, 2025 · finance.yahoo.com
growth-positive
DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest
PIPEInvestment
Sep 25, 2025 · finance.yahoo.com
growth-positive
DarioHealth Weighs Big Moves After Surprise Interest From Suitors
PartnersInvestmentPIPEManagement Changes
Sep 25, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in digital health solutions for chronic condition management, today...
InvestmentPIPEPartners
Sep 22, 2025 · finance.yahoo.com
growth-positive
DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules
PIPE
Sep 22, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a private placement...
Investment
Sep 3, 2025 · finance.yahoo.com
growth-positive
DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market
CustomersPartners
Sep 3, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today issued a shareholder update...
CustomersPartners
Sep 2, 2025 · finance.yahoo.com
growth-positive
Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025
CustomersProduct Stage
Aug 25, 2025 · finance.yahoo.com
growth-negative
DarioHealth Announces 20-to-1 Reverse Stock Split
Aug 25, 2025 · www.prnewswire.com
growth-negative
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced that a reverse stock...
Aug 14, 2025 · finance.yahoo.com
growth-negative
Some Analysts Just Cut Their DarioHealth Corp. (NASDAQ:DRIO) Estimates
Aug 13, 2025 · finance.yahoo.com
growth-positive
Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk
Aug 13, 2025 · finance.yahoo.com
growth-positive
Global Digital Therapeutics Market Experiencing Rapid Growth at a CAGR of ~28% by 2032 Amid Rising Demand for Personalized Healthcare| DelveInsight
Aug 12, 2025 · finance.yahoo.com
growth-negative
DarioHealth Corp. (DRIO) Reports Q2 Loss, Misses Revenue Estimates
+ 201 more articles
Details
Product Stage
Released
Employees
201-500
Exact Count
237
District
Center District
Founded
2011
Registrar
514668466
Crunchbase
labstyle-innovations
Locations
Ha-Tokhen Street 8, Caesarea, Israel
London, UK
142 West 57th Street, New York, NY, USA
Links
Website
LinkedIn
Twitter
Facebook
Careers
Admin
Last Update
Oct 17, 2025
Verified by
Yanina Wainscheinker
Missing
markets, not claimed
Team (9)
Rick Anderson
President & General Manager North America
Erez Raphael
CEO
Dov Oppenheim
Co-founder (No longer with the company)
Founder
Zvi Ben-David
CFO
Dror Bacher
COO, General Manager Israel
Omar Manejwala
Chief Medical Officer
Limor Drezner
VP HR & Chief of Staff
Joshua Fischer
SVP Operations and Compliance
Eyal Rivlin
SVP, Business Operations & B2C
Internal
Created by
Sophie Pollock (pollos@blair.edu)
Created
2014-06-23T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Status
Public on NASDAQ on Feb, 2013;